Inke S.A: APIs manufacturing plant.
01 1Inke SA
02 1Dr. Reddy's Laboratories Limited
03 2Glenmark Life Sciences Limited
04 1Hetero Drugs Limited
05 1Jubilant Pharmova Limited
06 3MSN Pharmachem Private Limited
07 1Novo Nordisk Production Ireland Limited
08 1OLON ACTIVE PHARMACEUTICAL INGREDIENTS INDIA PRIVATE LIMITED
09 1Optimus Drugs Private Limited
10 1Piramal Pharma Limited
11 1SOLARA ACTIVE PHARMA SCIENCES LIMITED
12 1Wisdom Pharmaceutical Co.,Ltd.
01 2APREPITANT
02 12Aprepitant
03 1aprepitant
01 1China
02 1Denmark
03 10India
04 1Italy
05 1Spain
06 1U.S.A
Inke S.A: APIs manufacturing plant.
NDC Package Code : 64567-0021
Start Marketing Date : 2021-01-14
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 55111-892
Start Marketing Date : 2012-08-02
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65372-1169
Start Marketing Date : 2012-12-12
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 50370-0022
Start Marketing Date : 2010-04-12
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 50370-0038
Start Marketing Date : 2013-06-30
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 50370-0048
Start Marketing Date : 2015-01-15
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 56125-634
Start Marketing Date : 2015-09-30
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER, FOR SUSPENSION (22kg/22kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 59285-015
Start Marketing Date : 2017-10-12
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65085-0043
Start Marketing Date : 2018-11-21
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (20kg/20kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 13612-0024
Start Marketing Date : 2021-10-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Aprepitant manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Aprepitant, including repackagers and relabelers. The FDA regulates Aprepitant manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Aprepitant API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Aprepitant manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Aprepitant supplier is an individual or a company that provides Aprepitant active pharmaceutical ingredient (API) or Aprepitant finished formulations upon request. The Aprepitant suppliers may include Aprepitant API manufacturers, exporters, distributors and traders.
click here to find a list of Aprepitant suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Aprepitant as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Aprepitant API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Aprepitant as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Aprepitant and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Aprepitant NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Aprepitant suppliers with NDC on PharmaCompass.
We have 12 companies offering Aprepitant
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
